Concepedia

Mats Inganäs

MI

31

Publications

2.8K

Citations

25

H-Index

1979

Active since

Affiliations

Uppsala University Hospital(Current)

Active Biotech (Sweden)

KTH Royal Institute of Technology

Karolinska University Hospital

Sophiahemmet Hospital

Mats Inganäs is an author at Uppsala University Hospital specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

1979–2010

31

Publications

31

The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry

S. Sjögren, Mats Inganäs, Torbjörn Norberg et al. · JNCI Journal of the National Cancer Institute · 1996 · 387 citations · Full text

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.

S. Sjögren, Mats Inganäs, A. Lindgren et al. · Journal of Clinical Oncology · 1998 · 330 citations

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

E. Berns, John A. Foekens, R. van Vossen et al. · PubMed · 2000 · 197 citations

, , +19

Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G.

Margareta Eliasson, Anders Olsson, Elisabeth Palmcrantz et al. · Journal of Biological Chemistry · 1988 · 179 citations · Full text

, , +19

A follow‐up study of children with food allergy. Clinical course in relation to serum IgE‐ and IgG‐antibody levels to milk, egg and fish

A Dannaeus, Mats Inganäs · Clinical & Experimental Allergy · 1981 · 170 citations

Rows per page

1–5 of 31